LATEST

Off the Wire

IN FOCUS

Second Chances at a Price: The High Stakes of Reoperation in Breast Cancer

A recent study published in the Annals of Surgical Oncology, has brought attention to a concerning trend in the treatment of breast cancer, specifically regarding breast-conserving surgery....

Omega-3 Fatty Acid and Breast Cancer Prevention for Patients Hoping for Pregnancy

A pilot trial at the National Cancer Institute, conducted by the University of Kansas Cancer Center and led by Principal Investigator Lauren Nye aims to explore the...

Nanotechnology-Enhanced Resveratrol Shows Promise in Treatment of Triple-Negative Breast Cancer

Yes, it's that kind of resveratrol--that found in red wine. But with a technical twist to ensure it's delivered properly. Triple-negative breast cancer (TNBC) is a type of...

LEARN MORE

RESEARCH

RESEARCH

LEARN MORE

New Research Shines Light on Hormone Therapy Resistance in Breast Cancer

Recent advancements in the research of hormone therapy resistance in advanced estrogen receptor (ER) positive breast cancers has revealed important considerations for future treatment. A...

Atossa Therapeutics Hits Milestone in Breast Cancer Trial with Full Enrollment

Atossa Therapeutics Inc has recently made an announcement about progress in one of its breast cancer studies. They've completed enrolling participants for a specific...

BriaCell Reveals Notable Results in Breast Cancer Treatment Trials

BriaCell Therapeutics Corp., a biotech firm focused on developing new treatments for cancer, recently shared promising results from their studies on breast cancer treatments....

Elacestrant Unveiled: A New Horizon for Hormone-Driven Breast Cancer

Patients with a type of breast cancer that grows in response to estrogen (ER-positive) but does not have the HER2 protein (HER2-negative) often start...

BCI Test Predicts Breast Cancer Recurrence Risk in Hormone Therapy Patients

The Breast Cancer Index (BCI) has been validated as a tool for predicting the risk of breast cancer recurrence in postmenopausal women treated with...

DRUG DEVELOPMENT